BG Medicine to Announce First Quarter 2013 Financial Results and Host Conference Call on Thursday, May 9, 2013

WALTHAM, Mass., May 2, 2013 (GLOBE NEWSWIRE) — BG Medicine, Inc. (BGMD) today announced that the company will host a conference call and webcast on Thursday, May 9 at 8:30 a.m. Continue reading

BG Medicine, Inc. to Present at Cowen and Company 33rd Annual Health Care Conference

WALTHAM, Mass., Feb. 27, 2013 (GLOBE NEWSWIRE) — BG Medicine, Inc. (BGMD) ), a company focused on the development and commercialization of novel cardiovascular diagnostics, announced today that Eric Bouvier, BG Medicine’s President and CEO, will be presenting at the Cowen and Company 33rd Annual Health Care Conference on March 4, 2013, at the Boston Marriott Copley Place, beginning at 2:10 PM Eastern Time (ET) Continue reading

BG Medicine, Inc. Announces Closing of Public Offering and Exercise of Over-Allotment Option

WALTHAM, Mass., Jan. 30, 2013 (GLOBE NEWSWIRE) — BG Medicine, Inc. (BGMD), a diagnostics company focused on the development and commercialization of novel cardiovascular tests, today announced the closing of its previously announced public offering of 6,000,000 shares of its common stock, as well as 900,000 additional shares of its common stock pursuant to the full exercise of the over-allotment option granted to the underwriter. Continue reading